Home » Topics » Regulatory

Regulatory
RSS

Lercanidipine 20 mg approved in Europe

March 7, 2003

Oral tazarotene completes phase III studies

March 7, 2003

Myoview approved for assessment of left ventricular function

March 6, 2003

Priority review granted for Arixtra sNDA

March 6, 2003

Avelox approved for CAP pneumonia due to penicillin-resistant S. pneumoniae

March 6, 2003

Positive opinion in E.U. for long-term use of Zometa

March 5, 2003

Avandia label broadened in the U.S.

March 4, 2003

FDA approves Oxytrol for overactive bladder

March 3, 2003

Risperdal Consta approved in Spain

Feb. 28, 2003

FDA approval for Gliadel Wafer during initial surgery for primary malignant glioma

Feb. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...